🚀 ProPicks AI Hits +34.9% Return!Read Now

West Virginia Senators Discuss Making Kratom, Delta-8 & Delta-9 Schedule 1 Drugs, Schools' New Policy On Medical Marijuana & Naloxone

Published 21/02/2023, 16:32
© Reuters.  West Virginia Senators Discuss Making Kratom, Delta-8 & Delta-9 Schedule 1 Drugs, Schools' New Policy On Medical Marijuana & Naloxone
IX
-

Benzinga - The Senate Judiciary Committee in West Virginia recently approved legislation that would place kratom, delta-8, and delta-10 products as Schedule 1 drugs.

Kratom, a tropical plant native to Southeast Asia, is currently not illegal and can produce effects similar to opioids. Delta-8 THC and delta-10 THC are chemical components of the cannabis plant, and although they occur naturally in very small concentrations, they can produce mild psychoactive effects in some people similar to delta-9 THC.

The bill will be assessed in the full Senate next week, and if turns into law it would remove these types of products from sales across the Mountain State, reported WVVA.

According to former U.S. Attorney and state senator Mike Stuart, approving this bill and eliminating these products is necessary because they often end up in children's hands. He claims that kratom, delta-8, and delta-10 could be similar to opioids in terms of addictive properties.

“If someone is operating a big piece of equipment and a high-wall collapses, the drug test will show there was nothing in their system and that’s just not true,” Stuart said. “And Delta 8 and Delta 10 are unneeded because we have medical marijuana, where if you follow the regulations, get the medical marijuana card, and go through the channels, it’s a lot safer.”

Another GOP state senator, Vince Deed, agreed. “Frankly, our kids are using it at record rates,” Deed said. “If you look at suspensions over the past 30 days, Lincoln County — 26 suspensions. Barbour County — 29 suspensions. These drugs of addiction only lead to misery. There will no doubt be individuals who claim the benefits of these drugs.”

Medical Cannabis, Naloxone In Schools Meanwhile, schools across the states are working on new sets of rules for enabling medical marijuana patients to use their cannabis safely at school.

At the Raleigh County Schools Board of Education meeting Tuesday night, assistant superintendent Serena Starcher and school health director Angie Foster presented new regulation dubbed medication administration and storage – standards for the possession and use of medical cannabis by a student, writes the Register-Herald, Beckley, W.Va.

Starcher and Foster also brought up the question of changing the regulation to allow for the administration of naloxone (an opioid overdose reversal drug) when needed during school.

Richard Snuffer, a Raleigh County board member, commented on the medical marijuana policy, saying it would “open up a can of worms.”

"I know we didn't open the can of worms, somebody else gave it to us ... but I see a lot of red flags in this thing, but that's just me," Snuffer said.

Under the proposed rules, which are put on 30-day comment, medical marijuana will not be kept on school property, and can’t be administered in dry leaf or plant form, only the following forms are approved: gummies, topicals, and tinctures. No school employees will be administering the substance.

Snuffer still thinks this will impose a heavy load on principals. "I understand that (medical cannabis) has helped a lot of people and stuff," he said, "it's just — I guess we'll learn as we go. I can see a lot of problems with it."

It seems that the new naloxone policy was more welcomed than medical marijuana. Board member Marie Hamrick said, “It just makes sense to me that it should be available for our kids.”

This comes almost two months after Danielle Walker, a Democratic member of the West Virginia House of Delegates, introduced House Bill 2091 which would legalize marijuana possession of one ounce or less of cannabis, and personal use for people 21 years or older.

Benzinga Cannabis Capital Conference Is Back The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition.

This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out.

Secure your tickets now. Prices will surge very soon.

Photo: Benzinga edit with images from Wikimedia Commons and Jamie Edwards on Unsplash

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.